GAITHERSBURG, Md., Dec. 4, 2014 /PRNewswire-USNewswire/ — Clongen Laboratories, LLC invites visitors to explore its new website and expanded test list. The new website is designed to be user-friendly, allowing customers to easily access the lists of clinical diagnostic services and contract research services provided.
Clongen announced eight new test offerings in August, 2014 to detect and identify emerging pathogens implicated in severe to fatal cases resulting from tick and other arthropod bites. “Clongen is now making over 100 additional real-time PCR-based diagnostic assays available by the end of the year, falling under the categories of urological and gynecological infections, respiratory pathogens, gastrointestinal pathogens, and dermatologic and soft tissue infections,” Dr. Ahmed Kilani said.
Clongen’s new website will provide straightforward navigation through the tests lists and access to updated clinical order forms. There will be ongoing additions to the website, including more links from the test menu to facts about each organism, plus credible and easy to follow journal articles. Users are urged to monitor the new site for exciting additions in the upcoming months.
“The overall focus of our laboratory remains unchanged since the company’s inception in 1999,” Kilani says. “While our focus is improving human health through the utilization of cutting edge technologies to provide the most accurate diagnostic assays, we strive to develop new tests for esoteric conditions that affect very small numbers of individuals as well as other infectious agents that have a broader patient population base.”
To view the new website and complete test menu, visit www.clongen.com
About Clongen Laboratories
A leader in molecular diagnostics, Clongen Laboratories is licensed in five states and holds two active FDA registrations. Since its inception in 2004, the company has enjoyed rapid growth and steadily expanded its menu offerings. Located in Gaithersburg, on the I-270 corridor in Montgomery County, MD, Clongen enjoys a strategic presence in close proximity to the National Institutes of Health, Johns Hopkins University, The University of Maryland, and other biotechnology institutions. Clongen Laboratories is a pioneer in developing innovative diagnostic tests utilizing rapid detection methods with the goal of improving human health. For more information, please visit www.clongen.com
Dr. Ahmed Kilani, President and Laboratory Director: 301-916-0173 x213
Elena Ralchenko, Office Manager: 301-916-0173 x200
SOURCE Clongen Laboratories
For PR Newswire link follow this link